Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Brain Cancer Now Leading Childhood Cancer Killer

By Mike Stobbe, AP Medical Writer | September 16, 2016

Brain cancer is now the deadliest childhood cancer in the U.S., now ahead of leukemia, a result of improved leukemia treatment and a frustrating lack of progress on brain cancer.

Government statisticians reported the change in rankings Friday, drawing from a review of 15 years of death certificates.

“I think most people, when they think of childhood cancer, think of leukemia,” said Sally Curtin of the Centers for Disease Control and Prevention. “This is kind of a changing of the guard.”

Cancer is the fourth leading cause of death for children overall, accounting for about 1 in 10 childhood deaths in 2014. About a quarter these cancer deaths, or 534, were due to brain cancer. There were 445 leukemia deaths.

Accidental injuries remained the leading cause of death for those under 19, followed by suicide and murder, according to the report.

There are still more new cases of leukemia each year than new cases of brain cancer, but it no longer accounts for the most deaths. That’s due to advances in leukemia treatment over the past few decades and because leukemia is easier than brain cancer to treat, experts said.

“Some types of leukemia that a generation ago were almost universally fatal are now almost universally treatable,” said Curtin, a statistician who worked on the report.

But the rate of death from brain cancer for children has held at about the same level for at least 15 years, according to the CDC report.

The trends are similar for adults, too, according to the American Cancer Society.

Leukemia is a type of cancer that affects the blood. That makes it easier for doctors to get to it and fight it with treatments like chemotherapy.

The brain is protected by a barrier which helps keeps many dangerous chemicals – including many cancer drugs – from getting to brain tissue or brain tumors. Surgery is difficult and sometimes impossible, depending on where the tumor is located in the brain. Radiation treatment can damage the development of a child’s brain.

“There’s survival, and then there’s survival at a price,” said Dr. Katherine Warren, an expert in pediatric brain tumor research at the National Cancer Institute.

Another factor is that scientists have only recently begun to understand that pediatric brain cancers may be biologically different from adult versions, and could require different approaches to treatment.

In 2014, the brain cancer death rate was about 0.7 per 100,000 children ages 1 through 19. The leukemia death rate was about 0.6. The overall pediatric cancer death rate dropped by about a fifth between 1999 and 2014, the CDC reported, helped by the reduction in leukemia deaths.

Related Articles Read More >

Medable’s Digital Data Flow Agent focuses on protocol translation as the agentic race accelerates
AI image firm Midjourney spins up health division, unveils ‘Ultrasonic CT’
Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
Genetically modified hookworms could produce and deliver therapeutics within a host
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE